Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial cell membranes and structural proteins represent a broad category of essential components that maintain the physical integrity and physiological functions of bacteria, fungi, and viruses (StatPearls, 2023). In bacteria, the cytoplasmic membrane is vital for osmotic regulation and nutrient transport, while structural proteins like FtsZ are required for cell division (PubMed, 2021). Fungal membranes are distinguished by the presence of ergosterol, which provides structural support and is a key target for polyene antifungals (NIH, 2022). These components are critical therapeutic targets because their disruption typically leads to rapid microbial death or loss of infectivity. For example, polymyxins destabilize the outer membrane of Gram-negative bacteria by binding to lipopolysaccharides, whereas daptomycin causes membrane depolarization in Gram-positive species (PubChem). Viral structural proteins, such as envelope glycoproteins, facilitate host cell attachment and are targets for various antiviral strategies (Nature, 2020). However, the therapeutic use of membrane-disrupting agents is often limited by potential toxicity to host cells, such as nephrotoxicity and neurotoxicity, due to similarities in lipid structures (PubMed, 2019).
Drugs targeting these components typically act by disrupting the physical integrity of the lipid bilayer, forming transmembrane pores, or binding to specific structural proteins to inhibit essential processes like cell division or viral entry (StatPearls, 2023; PubChem).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial cell membrane and structural proteins.